tirzepatide surpass cvot AHA 25: SURPASS-CVOT:Tirzepatide vs Dulaglutide for Heart Failure in T2D SURPASS-CVOT trial: Tirzepatide was non-inferior
Pay in 4 interest-free payments of $6.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























